Trial intelligence / Profile preview

KI1001 (Circadin) for Sleep Quality in Insomnia Patients ≥ 55 Years

NCT02087722Phase 3Completed

Sponsor
Kuhnil Pharmaceutical
Start
Aug 2013
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in Insomnia, sponsored by Kuhnil Pharmaceutical. Started Aug 2013; status: completed.

02

Drugs

melatonin
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT02087722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02087722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call